BCL2 and lung carcinoma: As a result, MA treatment potently promoted the apoptosis of several lung cancer cell lines in a dose-dependent manner (Figures 1D, E; Supplementary Figures S1E, F) and downregulated the antiapoptotic protein of BCL2 (Supplementary Figure S1G).